AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 89 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $29,000 | -50.0% | 12,350 | +1.1% | 0.00% | – |
Q4 2021 | $58,000 | -50.4% | 12,212 | -17.1% | 0.00% | – |
Q3 2021 | $117,000 | +30.0% | 14,726 | +12.9% | 0.00% | – |
Q2 2021 | $90,000 | -84.5% | 13,045 | -79.2% | 0.00% | – |
Q2 2020 | $580,000 | +130.2% | 62,668 | +138.0% | 0.00% | – |
Q3 2018 | $252,000 | -34.0% | 26,333 | -27.0% | 0.00% | – |
Q2 2018 | $382,000 | – | 36,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $532,000 | 6.17% |
Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |